Newsfeeds Archive - Spark Newswire

2 minute read

IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer’s-Associated Agitation

April 16, 11:47 AM

IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer's agitation. Results suggest significant reduction in agitation with minimal side effects compared to placebo.

IGC

3 minute read

Psyched: Three Noteworthy Psychedelics M&As, Colorado’s Regulations, Exclusive Financing & More

By Lara Goldstein

September 5, 10:07 AM

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

ATAI

2 minute read

Mindset Pharma’s $60M Acquisition, Otsuka’s Leap Into Next-Gen Psychiatry Solutions

By Lara Goldstein

August 31, 1:54 PM

Canadian next-generation psychedelics developer Mindset Pharma (OTCMKTS: MSSTF) has entered into a definitive agreement to acquire all outstanding shares of Otsuka America Inc. the U.S. arm of Otsuka Pharmaceutical Co. in an all-cash transaction for approximately $60 (CA$80) million.

CYBN

2 minute read

Regulatory Setback For Medtronic’s High Blood Pressure Device – FDA Backed Japanese Firms’ Similar Device For Uncontrolled Hypertension

By Vandana Singh

August 24, 8:45 AM

Medtronic Plc (NYSE: MDT) says the FDA Circulatory System Devices Panel (CSDP) voted unanimously (13-0) on safety and in favor (7-6) of the effectiveness of the Symplicity blood pressure procedure,

MDT

1 minute read

Individuals With Uncontrolled Hypertension – FDA Adcomm Panel Just Supported Japanese MedTech’s Blood Pressure Treatment Device

By Vandana Singh

August 23, 9:34 AM

The FDA's Circulatory Systems Devices Panel of the Medical Devices Advisory Committee backed Recor Medical Inc and its parent company, Otsuka Medical Devices Co Ltd's</

OTSKF

1 minute read

Japan’s Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer’s Agitation

By Vandana Singh

May 11, 8:53 AM

Otsuka Pharmaceutical Co Ltd (OTC: OTSKF) (OTC: OTSKY) (Otsuka) and H.

OTSKF

3 minute read

Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here’s What We Know

By Lara Goldstein

July 19, 2:27 PM

Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras.

BMY